Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
dehaze logo — Detecting chronic diseases before symptoms occur.

dehaze

Detecting chronic diseases before symptoms occur.

Founded 2023 Germany Germany 15 employees Seed Total: $3.22M AI, Health Care

General Information

Company Name dehaze
Founded Year 2023
Location Germany Germany
Employees 15
Industries AI, Health Care
Funding Stage Seed
Business Model B2B, B2C, B2B2C
Revenue Model Subscription, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with dehaze. To contact dehaze, visit dehaze.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does dehaze compare?

A PDF of dehaze and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting dehaze soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About dehaze

dehaze is a promising startup founded in 2023, headquartered in Germany, operating at the intersection of AI and Health Care. Their slogan, "Detecting and personally intervening chronic diseases before symptoms occur," captures the essence of their mission. The company aims to revolutionize healthcare by identifying chronic diseases early enough to improve patient outcomes significantly.

Their core value proposition is built around a proprietary AI model that highlights overlooked diagnoses and anticipates health risks through a three-step process. This involves harmonizing patient data, utilizing AI to flag anomalies, and disseminating these insights proactively to clinicians and patients for immediate action.

The company's potential has already attracted investment, securing a $20.00K Pre Seed Round on October 9, 2023, supported by Techstars. This strategic funding positions dehaze to enhance its technology and expand its market reach, making it an intriguing prospect for investors looking to support innovative healthcare solutions.

Business keywords: Chronic Disease Detection, AI in Healthcare, Predictive Analytics, Patient Data Management, Health Risk Assessment, Early Diagnosis, Personalized Healthcare, Clinical Insights, Healthcare AI Models, Medical Data Harmonization, Proactive Health Intervention, Health Trajectory Analysis

Services & Products

AI-driven risk notifications
Proactive health monitoring
Data cleansing and harmonization
AI-guided interventions

Target Customers

Patients Healthcare Providers Health Insurance Payers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €3.20M 5
Angel Invest Better Ventures DN Capital
Angel Invest, Better Ventures +3
28 Apr 2026
Pre Seed Round $20.00K 1
Techstars
Techstars
09 Oct 2023

Latest News

View All
dehaze raises €3.2M for AI chronic disease detection — Tech
dehaze raises €3.2M for AI chronic disease detection
Tech Apr 28, 2026

dehaze Alternatives & Competitors

View All Alternatives
dehaze vs
Twinn Health
Twinn Health United Kingdom

Twinn Health: See tomorrow’s health, Today.

Seed
1 employees
AI, Health Care
dehaze vs
Carenostics
Carenostics United States

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and...

Seed
13 employees
AI, Biotechnology
dehaze vs
Labplus
Labplus Poland

Transforming laboratory results into personalized health guidance for patients

Pre-Seed
39 employees
AI, Health Care
View all alternatives

FAQ About dehaze

Detecting chronic diseases before symptoms occur.
dehaze was founded in 2023.
dehaze is headquartered in Germany.
dehaze operates in AI and Health Care. Its work centres on Chronic Disease Detection, AI in Healthcare, Predictive Analytics and Patient Data Management. Its customers include Patients, Healthcare Providers and Health Insurance Payers.
dehaze has a B2B, B2C and B2B2C business model. Its revenue comes from Subscription, Service Fee and Usage Based.
dehaze has approximately 15 employees.
dehaze has completed 2 funding rounds, raising a total of $3.22M. The latest funding stage is Seed.
dehaze offers: AI-driven risk notifications, Proactive health monitoring, Data cleansing and harmonization, AI-guided interventions.
Top alternatives and competitors to dehaze include Twinn Health, Carenostics, Labplus, XUND, Renalytix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
dehaze and Twinn Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for dehaze, https://bouncewatch.com/company/dehaze, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes